James Vane
Stock Analyst at Jefferies
(0.93)
# 3,991
Out of 5,055 analysts
519
Total ratings
48.1%
Success rate
-1.2%
Average return
Main Sectors:
Stocks Rated by James Vane
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: FRE Fresenius SE & Co. KGaA | Reiterated: Buy | €55.00 | €43.56 | +26.26% | 85 | Oct 5, 2026 | |
| ETR: GXI Gerresheimer AG | Reiterated: Hold | €34.10 → €26.80 | €29.48 | -9.09% | 41 | Sep 30, 2026 | |
| LON: CVSG CVS Group plc | Reiterated: Hold | 1,400p | 1,230p | +13.82% | 19 | Sep 25, 2026 | |
| LON: HIK Hikma Pharmaceuticals PLC | Reiterated: Buy | 2,025p | 1,602p | +26.40% | 29 | Sep 25, 2026 | |
| SWX: SDZ Sandoz Group AG | Reiterated: Buy | CHF 93.00 → CHF 94.00 | CHF 73.82 | +27.34% | 8 | Sep 10, 2026 | |
| ETR: MRK Merck KGaA | Reiterated: Hold | €144.00 | €141.90 | +1.48% | 7 | Sep 3, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Reiterated: Hold | €17.30 | €24.50 | -29.39% | 10 | Aug 12, 2026 | |
| ETR: FME Fresenius Medical Care AG | Reiterated: Sell | €31.00 → €30.00 | €38.33 | -21.73% | 93 | Aug 11, 2026 | |
| EPA: VIRP Virbac SA | Reiterated: Hold | €361.00 → €360.00 | €335.00 | +7.46% | 14 | Jul 31, 2026 | |
| SWX: LONN Lonza Group AG | Reiterated: Buy | CHF 798.00 → CHF 781.00 | CHF 585.40 | +33.41% | 14 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | zł 188.00 → zł 176.00 | zł 159.00 | +10.69% | 4 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 827p | 512p | +61.52% | 4 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 94.50 → CHF 88.00 | CHF 69.60 | +26.44% | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €83.50 → €64.20 | €59.05 | +8.72% | 9 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 110.00 | CHF 122.66 | -10.32% | 2 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €307.00 | €258.00 | +18.99% | 34 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €210.00 → €246.00 | €205.50 | +19.71% | 2 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €229.00 → €262.00 | €216.40 | +21.07% | 13 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $22.47 | - | 24 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | CHF 49.30 | CHF 82.30 | n/a | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 260p → 298p | 248p | n/a | 17 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €49.00 → €61.50 | €53.00 | n/a | 3 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $13 | $34.16 | n/a | 30 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $17 → $18 | $21.54 | n/a | 8 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9.3 → $11 | $12.34 | n/a | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €4.49 | €3.35 | n/a | 7 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €49.00 | €40.07 | n/a | 23 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 147.00 → CHF 148.00 | CHF 92.56 | n/a | 4 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | 300p | 235p | n/a | 1 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €135.00 → €43.00 | €10.19 | n/a | 2 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.38 | n/a | 1 | Dec 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 93.00 | kr 263.50 | n/a | 1 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $31 | $12.75 | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $42.03 | n/a | 1 | Aug 21, 2017 |
Fresenius SE & Co. KGaA
Oct 5, 2026
Reiterated: Buy
Price Target: €55.00
Current: €43.56
Upside: +26.26%
Gerresheimer AG
Sep 30, 2026
Reiterated: Hold
Price Target: €34.10 → €26.80
Current: €29.48
Upside: -9.09%
CVS Group plc
Sep 25, 2026
Reiterated: Hold
Price Target: 1,400p
Current: 1,230p
Upside: +13.82%
Hikma Pharmaceuticals PLC
Sep 25, 2026
Reiterated: Buy
Price Target: 2,025p
Current: 1,602p
Upside: +26.40%
Sandoz Group AG
Sep 10, 2026
Reiterated: Buy
Price Target: CHF 93.00 → CHF 94.00
Current: CHF 73.82
Upside: +27.34%
Merck KGaA
Sep 3, 2026
Reiterated: Hold
Price Target: €144.00
Current: €141.90
Upside: +1.48%
SCHOTT Pharma AG & Co. KGaA
Aug 12, 2026
Reiterated: Hold
Price Target: €17.30
Current: €24.50
Upside: -29.39%
Fresenius Medical Care AG
Aug 11, 2026
Reiterated: Sell
Price Target: €31.00 → €30.00
Current: €38.33
Upside: -21.73%
Virbac SA
Jul 31, 2026
Reiterated: Hold
Price Target: €361.00 → €360.00
Current: €335.00
Upside: +7.46%
Lonza Group AG
Jul 28, 2026
Reiterated: Buy
Price Target: CHF 798.00 → CHF 781.00
Current: CHF 585.40
Upside: +33.41%
Jul 13, 2026
Reiterated: Hold
Price Target: zł 188.00 → zł 176.00
Current: zł 159.00
Upside: +10.69%
Jun 2, 2026
Reiterated: Buy
Price Target: 827p
Current: 512p
Upside: +61.52%
May 13, 2026
Reiterated: Hold
Price Target: CHF 94.50 → CHF 88.00
Current: CHF 69.60
Upside: +26.44%
May 13, 2026
Reiterated: Hold
Price Target: €83.50 → €64.20
Current: €59.05
Upside: +8.72%
Apr 28, 2026
Reiterated: Hold
Price Target: CHF 110.00
Current: CHF 122.66
Upside: -10.32%
Apr 23, 2026
Reiterated: Buy
Price Target: €307.00
Current: €258.00
Upside: +18.99%
Mar 18, 2026
Reiterated: Buy
Price Target: €210.00 → €246.00
Current: €205.50
Upside: +19.71%
Mar 17, 2026
Reiterated: Buy
Price Target: €229.00 → €262.00
Current: €216.40
Upside: +21.07%
Jan 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $22.47
Upside: -
Sep 25, 2025
Initiated Coverage: Sell
Price Target: CHF 49.30
Current: CHF 82.30
Upside: n/a
Aug 15, 2025
Reiterated: Buy
Price Target: 260p → 298p
Current: 248p
Upside: n/a
Aug 11, 2025
Upgraded: Buy
Price Target: €49.00 → €61.50
Current: €53.00
Upside: n/a
Feb 25, 2025
Reiterated: Buy
Price Target: $16 → $13
Current: $34.16
Upside: n/a
Aug 8, 2024
Reiterated: Sell
Price Target: $17 → $18
Current: $21.54
Upside: n/a
May 14, 2024
Reiterated: Buy
Price Target: $9.3 → $11
Current: $12.34
Upside: n/a
Jan 5, 2024
Reiterated: Hold
Price Target: €4.49
Current: €3.35
Upside: n/a
Nov 8, 2023
Reiterated: Hold
Price Target: €49.00
Current: €40.07
Upside: n/a
Feb 23, 2023
Reiterated: Buy
Price Target: CHF 147.00 → CHF 148.00
Current: CHF 92.56
Upside: n/a
Nov 22, 2022
Initiated Coverage: Buy
Price Target: 300p
Current: 235p
Upside: n/a
Jan 28, 2022
Downgraded: Hold
Price Target: €135.00 → €43.00
Current: €10.19
Upside: n/a
Dec 5, 2019
Downgraded: Hold
Price Target: n/a
Current: $9.38
Upside: n/a
Nov 1, 2018
Reiterated: Buy
Price Target: kr 93.00
Current: kr 263.50
Upside: n/a
Nov 1, 2017
Reiterated: Sell
Price Target: $31
Current: $12.75
Upside: n/a
Aug 21, 2017
Upgraded: Hold
Price Target: n/a
Current: $42.03
Upside: n/a